Pick Up
May. 17, 2022
Left main and complex bifurcation PCI in high bleeding risk patients
Tools and Techniques in EuroPCR 2022 / May. 17 - 20, 2022 / Paris, France and Online
May. 17, 2022
Trans-radial approach, from complex PCI to peripheral intervention
Tools and Techniques in EuroPCR 2022 / May. 17 - Sep. 20, 2022 / Paris, France and Online
Mar. 19, 2022
Master Class -DAPT Practice in Asia Pacific-
Master Class Webinar / Mar. 19, 2022 / Hybrid
Jan. 21, 2022
Navigating Through Complex Lesions in PCI
Singapore LIVE 2022 ONLINE / Jan. 21, 2022 / Online
Aug. 27, 2021
MASTER DAPT Clinical Study at a Glance
ESC (European Society of Cardiology) / Aug. 27 - 30, 2021 / Europe
Nov. 04, 2021
Outcomes in High Bleeding Risk Patients with High Thrombotic and Ischemic Risk
TCT 2021 LBT (Transcatheter Cardiovascular Therapeutics) / Nov. 04 - 06, 2021 / US
Information
Left main and complex bifurcation PCI in high bleeding risk patients
Event | Tools and Techniques in EuroPCR 2022/ May 17-20, 2022 / Paris, France and Online |
Anchorperson | T. Cuisset |
Moderator | G.G. Toth |
Discussants | F. Burzotta, M. Lesiak |
Operators | P. Garot, T. Lefèvre, Y. Onuma |
Medical control desk | E. Asher |
Session objectives |
|
Trans-radial approach, from complex PCI to peripheral intervention
Event | Tools and Techniques in EuroPCR 2022/ May 17-20, 2022 / Paris, France and Online |
Anchorperson | J. Fajadet |
Moderator | S. Kedev |
Discussants | A. Aminian, M. Roffi |
Session objectives |
|
Master Class -DAPT Practice in Asia Pacific-
Event | Master Class Webinar /Mar 19, 2022, 14:30-16:45 (GMT+8) / Hybrid |
Contents | Through this discussion, you can...
|
Event | Singapore LIVE 2022 ONLINE / Jan 21, 2022, 11:00-11:55 (SGT) / Online |
Session objectives |
|
MASTER DAPT Clinical Study at a Glance
Event | ESC (European Society of Cardiology) / Aug, 2021 / Europe |
Contents | Get an overview of the MASTER DAPT study in this interview with principle investigator of MASTER DAPT trial, Dr. Marco Valgimigli, talking at ESC 2021. Watch the interview to learn about the study design and primary endpoints, evidence of the non-inferiority of short DAPT, and how to apply the results to your clinical practice. |
Outcomes in High Bleeding Risk Patients with High Thrombotic and Ischemic Risk
Event | TCT 2021 LBT (Transcatheter Cardiovascular Therapeutics) / Nov, 2021 / US |
Contents | Find out more about the results from the subgroup analysis of the MASTER DAPT study and how the results bridge the current knowledge gap on DAPT duration in HBR patients in this presentation by Dr. Pieter C. Smits, principle investigator of MASTER DAPT study, from TCT 2021. Watch the webinar to gain new insights into clinical outcomes for high bleeding risk patients with high thrombotic and ischemic risks, and discover how the results can help you select the optimal DAPT strategy for your patients. Register free with TCTMD to access the video. |
The Unknown HBR Patient: Deep Dive into DAPT durations for HRB Patients
Event | DAPT meets its MASTER in Incathlab Webinar (Media) / Nov, 2021 / Europe |
Contents | In this conversation between three European experts, learn how to master the latest data on HBR patients and DAPT duration, the potential impact the study has on clinical practices, and how you can put the evidence for short DAPT with HBR patients into practice, as they discuss the MASTER DAPT study and HBR cases. Register free with Incathlab to watch. |
MASTER DAPT Outcomes - Panel Discussion
Event | AICT-AsiaPCR2021 / Oct, 2021 / Asia Pacific |
Contents | In this panel session dedicated to the study, learn more about the results of MASTER DAPT, what it means to patients and doctors, and how the clinical evidence proving the non-inferiority of short DAPT to standard could potentially impact the guidelines for DAPT duration in HBR patients. |
Practical Applications of MASTER DAPT at Japan's Leading Hospital
Event | East Asia PCI MASTER2021 - The Management of HBR patients / Oct, 2021 / Hong Kong & Taiwan |
Contents | Learn how to implement an optimized DAPT protocol for HBR patients in this lecture by Dr. Takashi Muramatsu. Dr Muramatsu is based at Fujita Health University Hospital, where the designed a short DAPT protocol for HBR patients based on the positive outcomes of the MASTER DAPT trial. |
Ultimaster™
Design ensuring better biocompatibility for long-term safety.
- Long term efficacy and safety proven by RCT in patients with complex background.
- Early healing by abluminal gradient coating and reduced drug dose.
- Reliable long-term patency by stronger vessel support and fracture resistance. ....more
Ultimaster™ Tansei™
Cross challenging anatomy with confidence. Advanced shaft technology for outstanding acute performance. Track complex lesions with ease. A tip designed to facilitate treatment of the most challenging cases.
- Updated exit port - smooth and balanced transition
- Advanced shaft technology - good transmission force and pushability, excellent kink resistance
- Innovative tip - Optimized durability and clear visibility ...more